Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
excellent points! thank you
he, can't, because there are none
that's what I think!
great post! great questions!
exactly
are they not even going to respond? Well done! lol
Ha! Ha! Ha! Ha! Ha!
exactly
WTF?
another great piece of valuable information, thanks
interesting DD, thanks Biowin
yes very good question!
real intelligent !
i.e. that was published a few days ago! your the best
great dd, need more posters, like you
great post
it does get any fresher than that, Aug.15th, 2022
nice to see you guys keep promoting KKR, no one else
is talking about it, let it go! lol
your exactly right, Biowin!
Ha! Ha! Ha!
more great DD Biowin!
lol, prove it, lets see your documents!
great, thank you
thank you for that intelligent input
Glues to the puzzle,
Mike Hartmann- “We believe that we are at the beginning of an evolution in the chemical industry where man has the ability to replace some chemicals that have been produced via the petro route with the same chemicals now using sugar as their source of carbon instead of fossil fuels”. Mike Hartmann, executive vice president of BioAmber, talks to Il Bioeconomista
BioAmber is a sustainable chemicals company, whose proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into building block chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products. The company, which is one of the main world bioeconomy’s players, has been listed on the New York Stock Exchange since May 2013, under the symbol BIOA. And is also listed on the NYSE Euronext Paris exchange, under the same symbol. BioAmber is a Delaware corporation with a head office in Montreal, Quebec, Canada, a research facility in Plymouth (Minneapolis), Minnesota, and a commercial plant operating in Sarnia, Ontario, Canada. Its investors include Sofinnova Partners (France), Naxos Capital Partners (Luxemburg), Mitsui & Co. (Japan), Lanxess (Germany) and the Cliffton Group (Canada). https://ilbioeconomista.com/2016/05/09/an-exclusive-interview-with-mike-hartmann-executive-vp-bioamber/
great info. I.E. and Biowin tonight, as always
beautiful
quit spreading false information!
yes some big names attached to bioamber, this is just a fascinating
restructuring, and were watching it unfold
exactly !!!
did you call Patrick?
you wish
i.e. fantastic DD, thanks
thank you biowin
thank you for that outstanding DD, iron-eagle
another great piece of info. thanks
Biowin you really know your stuff! amazing thank you
https://www.thefreelibrary.com/-Bluewater+Biochemicals+to+set+up+first+North+American+biosuccinic...-a0265583862
interesting